Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FYW73
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,561
Award facts
- Contract value 100% obligated
- $8,561.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $8,561.10 by the Defense Logistics Agency for the supply of Xolair 150 mg/ml autoinjector. This firm fixed-price delivery order, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, was awarded without set-aside designation. The contract represents a single task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for Department of Defense healthcare facilities worldwide.
Xolair (omalizumab) is a biologic medication primarily used for moderate-to-severe allergic asthma and chronic urticaria treatment. DMS Pharmaceutical Group's role as the prime contractor involves direct distribution of this specialty pharmaceutical to military health facilities. The company's consistent positioning as a preferred supplier for DLA pharmaceutical requirements reflects its established capability in managing complex pharmaceutical logistics and distribution networks supporting federal healthcare operations across the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FYW73?
SPE2DB25FYW73 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FYW73 worth?
The government has obligated $8,561 on SPE2DB25FYW73.
Is contract SPE2DB25FYW73 an order under another contract?
Yes. SPE2DB25FYW73 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYW73 competed?
The extent of competition for SPE2DB25FYW73 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award